MAM
AST.WS

McCarthy Asset Management’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

McCarthy Asset Management’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed – – 402
2021
Q2 		$0 Hold
2
– – ﹤0.01% 448
2021
Q1 		$0 Hold
2
– – ﹤0.01% 427
2020
Q4 		$0 Buy
+2
New – ﹤0.01% 381

McCarthy Asset Management's AST.WS Position: Q3 2021 in Review

McCarthy Asset Management sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2021, closing a stake of 2 shares.

McCarthy Asset Management first reported a position in AST.WS in Q4 2020 and held it in 3 quarters. The position peaked at $0 in Q2 2021. 0 funds tracked by Wall St. Rank hold AST.WS as of Q3 2021.

  • McCarthy Asset Management reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2021 after selling out during the quarter.
  • McCarthy Asset Management sold 2 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2021.
  • McCarthy Asset Management first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q4 2020 and held it in 3 quarters.
  • McCarthy Asset Management's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2021.

Based on McCarthy Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.